Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-02-13 8:05 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 12,584,459 (Direct) | View |
| 2023-02-07 Conversion | 2023-02-09 7:12 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director | 123,508 | $0 | 123,508 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 7:09 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Farid Ramy Director | 642,245 | $0 | 3,535,495 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 2:42 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 | 5,816,554 | $0 | 4,769,404 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 2:04 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 | 6,473,761 | $0 | 624,239 (Indirect) | View |
| 2023-02-02 Option Award | 2023-02-06 4:47 pm | N/A 2033-02-01 | Structure Therapeutics Inc. | GPCR | Yoon Jun Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 4:45 pm | N/A 2033-02-01 | Structure Therapeutics Inc. | GPCR | Stevens Raymond C Chief Executive Officer | 1,600,000 | $0 | 1,600,000 (Direct) | View |
Ownership | 2023-02-02 6:34 pm | N/A 2032-12-18 | Structure Therapeutics Inc. | GPCR | Waldstreicher Joanne Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:30 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 10% Owner | 0 | $0 | 6,473,761 (Indirect) | View |
Ownership | 2023-02-02 6:29 pm | N/A 2032-12-18 | Structure Therapeutics Inc. | GPCR | DOBMEIER ERIC Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:26 pm | N/A 2032-05-11 | Structure Therapeutics Inc. | GPCR | TETLOW SHARON Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:24 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Farid Ramy Director | 0 | $0 | 3,260,495 (Indirect) | View |
Ownership | 2023-02-02 6:23 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director | 0 | $0 | 1,302,630 (Indirect) | View |
Ownership | 2023-02-02 6:21 pm | N/A 2032-01-19 | Structure Therapeutics Inc. | GPCR | Ma Yingli Chief Technology Officer | 0 | $0 | 400,000 (Direct) | View |
Ownership | 2023-02-02 6:19 pm | N/A 2031-09-22 | Structure Therapeutics Inc. | GPCR | Jung Melita Sun Chief Business Officer | 0 | $0 | 465,290 (Direct) | View |
Ownership | 2023-02-02 6:13 pm | N/A 2031-09-22 | Structure Therapeutics Inc. | GPCR | Bach Mark Allen Chief Medical Officer | 0 | $0 | 581,610 (Direct) | View |
Ownership | 2023-02-02 6:12 pm | N/A 2029-09-10 | Structure Therapeutics Inc. | GPCR | Lin Xichen Chief Scientific Officer | 0 | $0 | 568,000 (Direct) | View |
Ownership | 2023-02-02 6:11 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 10% Owner | 0 | $0 | 5,816,554 (Indirect) | View |
Ownership | 2023-02-02 6:09 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Yoon Jun Chief Financial Officer | 0 | $0 | 2,818,250 (Direct) | View |
Ownership | 2023-02-02 6:07 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Stevens Raymond C Chief Executive Officer | 0 | $0 | 3,257,017 (Direct) | View |